Actions of Pharmaceutical Lactones and Lactams on the Enzymes with Lactonase Activity: In Silico Prediction and In Vitro Study. [PDF]
Efremenko E +3 more
europepmc +1 more source
Novel Therapeutic Approaches and Alternatives to Antibiotic Therapy for Drug-Resistant Intra-Abdominal Infections. [PDF]
Toma EA +8 more
europepmc +1 more source
Prevalence of carbapenemase production among Enterobacterales with reduced susceptibility to meropenem in patients at Hospital de Clínicas de Porto Alegre (HCPA) between 2019 and 2024. [PDF]
Filter EL +6 more
europepmc +1 more source
ESKAPEE Microorganisms and the Art of Escape: From Antimicrobial Resistance Mechanisms to the One Health Approach. [PDF]
Krul D +5 more
europepmc +1 more source
<i>Escherichia coli</i> with penicillin-binding protein 3 insertions: implications for newer β-lactam/β-lactamase inhibitor combinations. [PDF]
Pitout JDD +4 more
europepmc +1 more source
In vitro activity of β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with aztreonam against metallo-β-lactamase producing Escherichia coli clinical isolates. [PDF]
Viguier C +6 more
europepmc +1 more source
National genomic surveillance of carbapenemase-producing <i>Escherichia coli</i> isolates in Slovenia, January 1st-December 31st 2023. [PDF]
Pirs M +6 more
europepmc +1 more source
Combating Carbapenem-Resistant <i>Enterobacterales</i>: Comparative <i>In Vitro</i> Efficacy of Aztreonam-Avibactam and Ceftazidime-Avibactam and Distribution of Carbapenemase Genes. [PDF]
Yaşar Duman M +4 more
europepmc +1 more source
Calciphylaxis complicated by NDM-1-producing Pseudomonas aeruginosa: first experience with cefepime-zidebactam alongside phage therapy in the USA. [PDF]
Ulloa ER +9 more
europepmc +1 more source
Covalent inhibition of New Delhi metallo-β-lactamases NDM-1 and NDM-5 by 3-bromopyruvate. [PDF]
Bradley JK +7 more
europepmc +1 more source

